glp 1 sales GLP-1 Receptor Agonist Market Size Worth $18.2 Billion By 2027 GLP-1 Receptor Agonist Market Size,
Description
To qualify for Ozempic as part of a weight loss program, patients will need to be considered obese, which is classified as having a BMI (body mass index) of 30 or higher, or be overweight, classified as having a BMI of 27 or higher, while also having a weight-related health condition
A single injection of 3 mg/kg of this antibody normalized blood glucose levels in obese mice over 8 days
Like most glucagon-like peptide-1 (GLP-1) receptor agonists, Saxenda is injected under the skin, once daily in this case, and works best when used alongside a low-calorie diet and routine physical activity
However, without robust appetite modulation, the long-term effect on body composition may be limited
